[1]王恬,夏骏*,兰央草,等.从祛风、化痰、逐瘀论治哮喘-慢阻肺重叠[J].中国中医药图书情报杂志,2021,45(6):70-74.[doi:10.3969/j.issn.2095-5707.2021.06.017]
 WANG Tian,XIA Jun*,LAN Yang-cao,et al.Treatment of ACO from Expelling Wind, Resolving Phlegm and Expelling Blood Stasis[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(6):70-74.[doi:10.3969/j.issn.2095-5707.2021.06.017]
点击复制

从祛风、化痰、逐瘀论治哮喘-慢阻肺重叠

参考文献/References:

[1] Orie N G M, Sluiter H J, De Vries K, et al. The host factor in bronchitis[C]// Proceedings of the International Symposium on Bronchitis. Groningen, 1961:43-59.
[2] Chambliss J M, Sur S, Tripple J W. Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5[J]. Curr Opin Allergy Clin Immunol, 2018,18(1):26-31.
[3] Global Initiative for Chronic Obstructive Lung Disease. Asthma, COPD, and asthma-COPD overlap syndrome[EB/OL].[2021-05-30].https://goldcopd.org/asthma-copd-asthma-copd-overlap-syndrome/.
[4] Yanagisawa S, Ichinose M. Definition and diagnosis of asthma-COPD overlap (ACO)[J]. Allergol Int, 2018,67(2):172-178.
[5] Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019[J]. Eur Respir J, 2019,53(5):1900164.
[6] Tashkin D P, Peebles R S Jr. Controversies in allergy: Is asthma chronic obstructive pulmonary disease overlap a distinct syndrome that changes treatment and patient outcomes?[J]. J Allergy Clin Immunol Pract, 2019,7(4):1142-1147.
[7] Lange P, Colak Y, Ingebrigtsen T S, et al. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis[J]. Lancet Respir Med, 2016,4(4):454-462.
[8] Hardin M, Cho M, McDonald M L, et al. The clinical and genetic features of COPD-asthma overlap syndrome[J]. Eur Respir J, 2014,44(2):341-350.
[9] Hosseini M, Almasi-Hashiani A, Sepidarkish M, et al. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis[J]. Respir Res, 2019,20(1):229.
[10] Plaza V, álvarez F, Calle M, et al. Consensus on the asthma-COPD overlap (ACO) between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma(GEMA) [J]. Archivos De Bronconeumología, 2017,53(8):443-449.
[11] Global Initiative for Asthma. GINA: Interim guidance about COVID-19 & Asthma[EB/OL].(2021-04-26)[2021-05-30].http://www.ginasthma.org/.
[12] Roman-Rodriguez M, Kaplan A. GOLD 2021 Strategy Report: Implications for asthma-COPD overlap[J]. International Journal of COPD, 2021,16:1709-1715.
[13] ZHOU A Y, LUO L J, LIU N, et al. Prospective development of practical screening strategies for diagnosis of asthma-COPD overlap[J]. Respirology, 2020,25(7):735-742.
[14] 丹波元坚.杂病广要[M].李洪涛,校.北京:中医古籍出版社,2002:2-3.
[15] 朱洁云,罗毅沣,王霄玲,等.BMI与慢性阻塞性肺病患者死亡率相关性的Meta分析[J].中国循证医学杂志,2019,19(7):811-817.
[16] 戴原礼.秘传证治要诀[M].北京:人民卫生出版社,2006:115-116.
[17] 张介宾.景岳全书[M].北京:中国中医药出版社,1994:235-239.
[18] 吴澄.不居集[M].北京:中国中医药出版社,2002:279-292.
[19] 胡燕,王孟清,荀春铮,等.王孟清教授从伏痰论治咳嗽变异性哮喘经验[J].湖南中医药大学学报,2020,40(3):305-308.
[20] Hikichi M, Hashimoto S, Gon Y. Asthma and COPD overlap pathophysiology of ACO[J]. Allergol Int, 2018,67(2):179-186.
[21] 唐容川.血证论[M].北京:人民军医出版社,2007:118-129.
[22] 郭山逸.余小萍教授应用虫类药物治疗咳嗽变异性哮喘临床经验[J].河北中医,2019,41(2):168-171.
[23] 冯涛.秦伯未解《西溪书屋夜话录》“治肝卅法”[J].山东中医药大学学报,2020,44(5):580-584.
[24] 陈修园.医学从众录[M].太原:山西科学技术出版社,1996:27-32.
[25] 柯诗文,曾丽珍,李少峰,等.浅析国医大师洪广祥“治痰治瘀以治气为先”学术思想[J].中华中医药杂志,2020,35(1):176-179.

备注/Memo

收稿日期:2021-07-30

基金项目:国家自然科学基金面上项目(81770286);江苏省中医院高峰学术人才培养项目(y2018rc29)
第一作者:王恬,E-mail: 1633302448@qq.com
*通讯作者:夏骏,E-mail: ricsummer@163.com

更新日期/Last Update:

2021-11-04